Skip to main content
NCBI home page
Atencion Primaria logoLink to Atencion Primaria
. 2013 Apr 5;30(10):648–654. [Article in Spanish] doi: 10.1016/S0212-6567(02)79128-2

Diferencias entre el asma y la enfermedad obstructiva crónica

K Naberan Toña 1,*
PMCID: PMC7679696  PMID: 12525342

The content is available as a PDF (299.7 KB).

Bibliografía

  • 1.Busquet Duran L., Naberan Toña K., Hernández Huet E. Protocolos de asma y enfermedad pulmonar obstructiva crónica (EPOC) en atención primaria. FMC Aten Primaria. 1994;1(Supl 4):1–40. [Google Scholar]
  • 2.Grupo Español del Estudio del Asma Prevalencia de hiperreactividad bronquial y asma en adultos jóvenes de cinco áreas españolas. Med Clin (Barc) 1996;106:761–767. [PubMed] [Google Scholar]
  • 3.Aguinaga Ontoso I., Arnedo Pena A., Bellido J., Guillem Grima F., Morales Suárez Valera M., por el grupo español del estudio I.S.A.A.C. Prevalencia de síntomas relacionados con el asma en niños de 13–14 años de 9 poblaciones españolas. Med Clin (Barc) 1999;112:171–175. [PubMed] [Google Scholar]
  • 4.Pereira A., Maldonado J.A., Sánchez M., Grávalos J., Pujol E., Gómez M. Síntomas respiratorios en población infantil. Estudio ISAAC (International Study of Asthma and Allergies in Childhood) Arch Bronconeumol. 1995;31:383–388. doi: 10.1016/s0300-2896(15)30877-2. [DOI] [PubMed] [Google Scholar]
  • 5.Sobradillo V., Miravitlles M., Jiménez C.A., Gabriel R., Viejo J.L., Masa J.F. Estudio IBERPOC en España: prevalencia de síntomas respiratorios habituales y de limitación crónica al flujo aéreo. Arch Bronconeumol. 1999;35:159–166. doi: 10.1016/s0300-2896(15)30272-6. [DOI] [PubMed] [Google Scholar]
  • 6.Broder I., Higgins M.W., Mathews K.P., Keller J.B. Epidemiology of asthma and allergic rhinitis in a total community, Tecumseh, Michigan III. Second survey of the community. J Allergy Clin Immunol. 1974;53:127–138. doi: 10.1016/0091-6749(74)90001-3. [DOI] [PubMed] [Google Scholar]
  • 7.Fletcher C., Peto R. The natural history of chronic airflow obstruction. BMJ. 1977;1:1645–1648. doi: 10.1136/bmj.1.6077.1645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Gillooly M., Eamb D. Microscopic emphysema in relation to age and smoking habit. Thorax. 1997;48:491–495. doi: 10.1136/thx.48.5.491. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Silverman E.K., Speizer F.E. Risk factors for the development of chronic obstructive pulmonary disease. Med Clin North Am. 1996;80:501–522. doi: 10.1016/s0025-7125(05)70451-x. [DOI] [PubMed] [Google Scholar]
  • 10.Davis R.M., Novotny T.E. The epidemiology of cigarette smoking and its impact on chronic obstructive pulmonary disease. Am Rev Respir Dis. 1989;140:S82–84. doi: 10.1164/ajrccm/140.3_Pt_2.S82. [DOI] [PubMed] [Google Scholar]
  • 11.Liu B.Q., Peto R., Chen Z.M., Boreham J., Wu Y.P., Li J.Y. Emerging tobacco hazards in China: retrospective proportional mortality study of one million deaths. BMJ. 1998;317:1411–1422. doi: 10.1136/bmj.317.7170.1411. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Daniels S.E., Bhattachanrya S., James A., Leaves N.I., Young A., Hill M.R. A genome-wide researche for quantitative trair loci underlying asthma. Nature. 1996;383:247–250. doi: 10.1038/383247a0. [DOI] [PubMed] [Google Scholar]
  • 13.Romagnani S. Induction of Th1 and Th2 responses: a key role for the natural immune response? Immunol Today. 1992;13:379–381. doi: 10.1016/0167-5699(92)90083-J. [DOI] [PubMed] [Google Scholar]
  • 14.Saetta M., Di Stefano A., Turato G., Facchini F.M., Corbino L., Mapp C.E. CD8+ T-lymphocytcs in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;157:822–826. doi: 10.1164/ajrccm.157.3.9709027. [DOI] [PubMed] [Google Scholar]
  • 15.Busse W., Lemanske R. Advances in immunology. N Engl J Med. 2001;344:350–362. doi: 10.1056/NEJM200102013440507. [DOI] [PubMed] [Google Scholar]
  • 16.Barnes P. Chronic Obstuctive Pulmonary Disease. N Engl J Med. 2000;343:269–280. doi: 10.1056/NEJM200007273430407. [DOI] [PubMed] [Google Scholar]
  • 17.Hill A.T., Bayley D., Stockley R.A.A. The interrelationship of sputum inflammatory markers in patients with chronic bronchitis. Am J Respir Crit Care Med. 1999;160:893–898. doi: 10.1164/ajrccm.160.3.9901091. [DOI] [PubMed] [Google Scholar]
  • 18.Pratico D., Basili S., Vieri M., Cordova C., Violi F., Fitzgerald G.A. Chronic obstructive pulmonary disease is associated with an increase in uri-nary levels of isoprostanc F2α-III, an index of oxidant stress. Am J Respir Crit Care Med. 1998;158:1709–1714. doi: 10.1164/ajrccm.158.6.9709066. [DOI] [PubMed] [Google Scholar]
  • 19.Shapiro S.D. Elastolytic metalloproteinases produced by human mononuclear phagocytes. Potential roles in destructive lung disease. Am J Respir Crit Care Med. 1994;150:S160–164. doi: 10.1164/ajrccm/150.6_Pt_2.S160. [DOI] [PubMed] [Google Scholar]
  • 20.Borish L.C., Nelson H.S., Lanz M.J., Clausen L., Whitemore J.B., Agosti J.M. Interleukin-4 receptor in moderate atopic asthma. A phase 17II randomized, placebo-controlled trial. Am J Respir Crit Care Med. 1999;160:1816–1823. doi: 10.1164/ajrccm.160.6.9808146. [DOI] [PubMed] [Google Scholar]
  • 21.Culpitt S.V., Maziak W., Loukidis S., Nightingale J.A., Matthews J.L., Barnes P.J. Effect of high dose inhaled steroid on cells, cytokincs, and pro-teases in induced sputum in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;160:1635–1639. doi: 10.1164/ajrccm.160.5.9811058. [DOI] [PubMed] [Google Scholar]
  • 22.Keatings V.M., Jatakanon A., Worsdell Y.M., Barnes P.J. Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. Am J Respir Crit Care Med. 1997;155:542–548. doi: 10.1164/ajrccm.155.2.9032192. [DOI] [PubMed] [Google Scholar]
  • 23.Nightingale J.A., Rogers D.F., Fan Chung K., Barnes P.I. No effect of inhaled budesonide on the response to inhaied ozone in normal subjects. Am J Respir Crit Care Med. 2000;161:479–486. doi: 10.1164/ajrccm.161.2.9905031. [DOI] [PubMed] [Google Scholar]
  • 24.Paggiaro P.L., Dahle R., Bakran I., Frith L., Hollingworth K., Efthimou J. Multicentre randomised-placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. Lancet. 1998;351:773–780. doi: 10.1016/s0140-6736(97)03471-5. [DOI] [PubMed] [Google Scholar]
  • 25.Saetta M., Di Stefano A., Maestrelli P., Turato G., Ruggieri M.P., Roggeri A. Airway eosinophilia in chronic bronchitis during exacerbations. Am J Respir Crit Care Med. 1994;150:1646–1652. doi: 10.1164/ajrccm.150.6.7952628. [DOI] [PubMed] [Google Scholar]
  • 26.Barnes P.J. New therapies for chronic obstructive pulmonary disease. Thorax. 1998;53:137–147. doi: 10.1136/thx.53.2.137. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Atencion Primaria are provided here courtesy of Elsevier

RESOURCES